Its a triple-action medication that mimics the effects of three hormones: GLP-1, GIP, and glucagon
Retatrutide and tesamorelin are both peptide-based compounds that have attracted significant interest in metabolic medicine, though they differ considerably in their origins, mechanisms, and clinical applications
weighed 198 lbs, a 40-lb weight loss with four inches off his waistline
Less expression is also described in other tissues such as the heart, pancreas, adipose tissue, and the GI tract
Combining two incretin-based therapies creates dangerous overlapping receptor activation
The first mechanism involves the enhancement of the reloading of the insulin pool available for immediate release, occurring only in the presence of incretin and at a certain glucose threshold